Antiplatelet and Anticoagulant Pharmacology for the Laboratory Professional (Online Course)

(based on 53 customer ratings)

Author: Kyle D. Mills, MLS(ASCP)SH
Reviewer: Katie Blain, PharmD, MPH

See all available courses »

Continuing Education Credits

  • P.A.C.E.® Contact Hours: 1.5 hour(s)
  • Florida Board of Clinical Laboratory Science CE - General (Hematology): 1.5 hour(s)


  • Identify the various components of the hemostatic system as being either promoters or inhibitors of coagulation.
  • Differentiate between the mechanism and purpose of primary coagulation, secondary coagulation, fibrinolysis, and natural coagulation inhibition.
  • Generalize the mechanism of action of various pharmacologic agents used to treat hemostatic disorders.
  • Predict which laboratory assay(s) is(are) used to monitor the effectiveness of a given hemostatic medications based on that medication's mechanism of action.
  • Recognize the potential toxicities of pharmacologic agents used in the treatment of hemostatic disorders.

Customer Ratings

(based on 53 customer ratings)

Course Outline

  • Course Information
      • Introduction
  • Review of Hemostasis Physiology
    • Basic Definitions and Components
      • Basic Definitions and Components
      • Overview of Thrombosis
    • Primary Coagulation
      • Primary Coagulation
      • Thromboxane A2 and ADP are exposed as a result of damage to a blood vessel wall, resulting in platelet adhesion and activation.
      • Platelet Production
    • Secondary Coagulation
      • Secondary Coagulation
      • _____ functions to reinforce the platelet plug at the site of bleeding.
      • The Coagulation Factors
      • Secondary Coagulation: Coagulation Cascade
      • Coagulation Pathway Summary Chart
      • Identify the following coagulation factors as being part of either the intrinsic or extrinsic pathway of the coagulation cascade.
    • Coagulation Inhibition and Fibrinolysis
      • Overview of Coagulation Inhibition and Fibrinolysis
      • Three Natural Inhibitors of Coagulation
      • Which of the following is a natural inhibitor of coagulation?
      • Fibrinolysis
  • Antiplatelet and Anticoagulant Pharmacology
    • Overview
      • Overview of Hemostasis and Thrombosis Pharmacology
    • Anticoagulants
      • Heparins: Heparin and Low-Molecular-Weight Heparin
      • Clinical Correlation: Heparin-Induced Thrombocytopenia (HIT)
      • What is the autoantibody implicated in heparin-induced thrombocytopenia (HIT)?
      • Warfarin
      • Heparin vs Warfarin Summary Chart
      • Identify if the property listed is applicable to heparin or warfarin.
      • Direct Factor Xa Inhibitors
      • Direct Thrombin Inhibitors
    • Antiplatelet Medications
      • Aspirin and other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
      • Aspirin produces an irreversible inhibition of platelets.
      • GP IIb/IIIa Inhibitors
      • ADP Receptor (P2Y12 Receptor) Inhibitors
      • A P2Y12 assay is used to measure the patient's response to aspirin.
    • Thrombolytics
      • Alteplase and Streptokinase
      • In a patient experiencing a stroke, tPA can be used for up to ____ hours after the onset of symptoms.
    • Coagulation Agonists
      • Overview of Coagulation Agonists
      • Coagulation Factors and Desmopressin
      • Clinical Correlation: Hemophilia A and B
      • Clinical Correlation: von Willebrand Disease (vWD)
      • Vitamin K
      • Identify if the coagulation factors listed are vitamin K-dependent or non vitamin K-dependent.
  • References
      • References

Additional Information

Level of Instruction: Intermediate

Intended Audience:  Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students, pathology residents, and other healthcare personnel who are responsible for prescribing and administering antiplatelet and anticoagulant medications.

Author Information: Kyle D. Mills, MLS(ASCP)SH is currently pursing a Doctor of Osteopathic Medicine at the University of Pikeville College of Osteopathic Medicine in Pikeville, Kentucky. He received his Bachelor of Health Science in Clinical Laboratory Sciences in 2011 at the University of Kentucky in Lexington, KY and his Medical Laboratory Specialist in Hematology (SH) from the American Society of Clinical Pathology (ASCP) in 2015. Kyle was previously the Medical Lab Technology Program Education Coordinator at the Medtech College in Lexington, KY and worked as an MLS at Baptist Health Lexington.

Reviewer Information: Katie Blain, PharmD, MPH is a pharmacist with the Appalachian Regional Healthcare health system in Eastern Kentucky and Southern West Virginia. Dr. Blain currently serves as the Kentucky Pharmacists Association (KPhA) New Practitioner Committee Chair. She completed an American Society of Health System Pharmacy (ASHP) accredited community pharmacy residency program with Sullivan University College of Pharmacy and Walgreens Co. in Louisville, Kentucky. Dr. Blain received her Doctor of Pharmacy and Master of Public Health degrees from the University of Kentucky.  

Course Description:  This course will reintroduce older pharmacologic therapies, as well as introduce new therapies. The course will begin with a review of hemostasis physiology, continue with an overview of antiplatelet and anticoagulant pharmacology as it stands today, and end with a review of coagulation assays that may be seen in the clinical laboratory.

Just one user? Visit for individual subscriptions.
049  Platelets.gif

coag tubes shutterstock